Nord/LB Reiterates “€92.00” Price Target for Carl Zeiss Meditec (AFX)

Share on StockTwits

Nord/LB set a €92.00 ($106.98) price target on Carl Zeiss Meditec (ETR:AFX) in a research note published on Monday. The brokerage currently has a buy rating on the stock.

A number of other analysts also recently issued reports on the stock. Berenberg Bank set a €68.00 ($79.07) price objective on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a report on Monday. Hauck & Aufhaeuser set a €78.50 ($91.28) target price on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research report on Thursday, January 24th. Independent Research set a €74.00 ($86.05) target price on shares of Carl Zeiss Meditec and gave the stock a sell rating in a research report on Tuesday, January 22nd. Kepler Capital Markets set a €62.00 ($72.09) target price on shares of Carl Zeiss Meditec and gave the stock a sell rating in a research report on Tuesday, January 15th. Finally, Deutsche Bank set a €71.00 ($82.56) target price on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research report on Tuesday, December 11th. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. Carl Zeiss Meditec presently has an average rating of Hold and a consensus price target of €72.31 ($84.08).

ETR AFX opened at €80.95 ($94.13) on Monday. Carl Zeiss Meditec has a 52-week low of €37.53 ($43.64) and a 52-week high of €55.25 ($64.24).

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

See Also: What are the reasons investors use put options?

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2019 BBNS.